RELMADA THERAPEUTICS, INC. (RLMD)
Nasdaq: RLMD · CIK 0001553643 · United States
Every official RELMADA THERAPEUTICS, INC. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RLMD filings
RELMADA THERAPEUTICS, INC. documents
- RELMADA THERAPEUTICS, INC. 10-K 2026RLMD 10-K 2026: annual report for fiscal 2026
- RELMADA THERAPEUTICS, INC. 10-K 2025RLMD 10-K 2025: annual report for fiscal 2025
- RELMADA THERAPEUTICS, INC. 10-K 2024RLMD 10-K 2024: annual report for fiscal 2024
- RELMADA THERAPEUTICS, INC. 10-K 2023RLMD 10-K 2023: annual report for fiscal 2023
- RELMADA THERAPEUTICS, INC. 10-K 2022RLMD 10-K 2022: annual report for fiscal 2022
- RELMADA THERAPEUTICS, INC. 10-Q 2026RLMD 10-Q 2026: quarterly report for fiscal 2026
- RELMADA THERAPEUTICS, INC. 10-Q 2025RLMD 10-Q 2025: quarterly report for fiscal 2025
- RELMADA THERAPEUTICS, INC. 10-Q 2024RLMD 10-Q 2024: quarterly report for fiscal 2024
- RELMADA THERAPEUTICS, INC. 10-Q 2023RLMD 10-Q 2023: quarterly report for fiscal 2023
- RELMADA THERAPEUTICS, INC. 10-Q 2022RLMD 10-Q 2022: quarterly report for fiscal 2022
- RELMADA THERAPEUTICS, INC. 8-K 2026RLMD 8-K 2026: current report for fiscal 2026
- RELMADA THERAPEUTICS, INC. 8-K 2025RLMD 8-K 2025: current report for fiscal 2025
- RELMADA THERAPEUTICS, INC. 8-K 2024RLMD 8-K 2024: current report for fiscal 2024
- RELMADA THERAPEUTICS, INC. 8-K 2023RLMD 8-K 2023: current report for fiscal 2023
- RELMADA THERAPEUTICS, INC. 8-K 2022RLMD 8-K 2022: current report for fiscal 2022
- RELMADA THERAPEUTICS, INC. DEF 14A 2026RLMD DEF 14A 2026: proxy statement for fiscal 2026
- RELMADA THERAPEUTICS, INC. DEF 14A 2025RLMD DEF 14A 2025: proxy statement for fiscal 2025
- RELMADA THERAPEUTICS, INC. DEF 14A 2024RLMD DEF 14A 2024: proxy statement for fiscal 2024
- RELMADA THERAPEUTICS, INC. DEF 14A 2023RLMD DEF 14A 2023: proxy statement for fiscal 2023
- RELMADA THERAPEUTICS, INC. DEF 14A 2022RLMD DEF 14A 2022: proxy statement for fiscal 2022
- RELMADA THERAPEUTICS, INC. Form 4 2026RLMD Form 4 2026: insider trading filing for fiscal 2026
- RELMADA THERAPEUTICS, INC. Form 4 2025RLMD Form 4 2025: insider trading filing for fiscal 2025
- RELMADA THERAPEUTICS, INC. Form 4 2024RLMD Form 4 2024: insider trading filing for fiscal 2024
- RELMADA THERAPEUTICS, INC. Form 4 2023RLMD Form 4 2023: insider trading filing for fiscal 2023
- RELMADA THERAPEUTICS, INC. Form 4 2022RLMD Form 4 2022: insider trading filing for fiscal 2022
- RELMADA THERAPEUTICS, INC. S-1 2026RLMD S-1 2026: registration statement for fiscal 2026
- RELMADA THERAPEUTICS, INC. S-1 2025RLMD S-1 2025: registration statement for fiscal 2025
- RELMADA THERAPEUTICS, INC. S-1 2024RLMD S-1 2024: registration statement for fiscal 2024
- RELMADA THERAPEUTICS, INC. S-1 2023RLMD S-1 2023: registration statement for fiscal 2023
- RELMADA THERAPEUTICS, INC. S-1 2022RLMD S-1 2022: registration statement for fiscal 2022
- RELMADA THERAPEUTICS, INC. 13F 2026RLMD 13F 2026: institutional holdings for fiscal 2026
- RELMADA THERAPEUTICS, INC. 13F 2025RLMD 13F 2025: institutional holdings for fiscal 2025
- RELMADA THERAPEUTICS, INC. 13F 2024RLMD 13F 2024: institutional holdings for fiscal 2024
- RELMADA THERAPEUTICS, INC. 13F 2023RLMD 13F 2023: institutional holdings for fiscal 2023
- RELMADA THERAPEUTICS, INC. 13F 2022RLMD 13F 2022: institutional holdings for fiscal 2022
More companies